Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures - Wikidata - wikimedia - TriplyDB

Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures

Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures

http://www.wikidata.org/entity/Q35954734

about

The role of trimetazidine in cardiovascular disease: beyond an anti-anginal agent Clinical effect of trimetazidine on prevention of contrast-induced nephropathy in patients with renal insufficiency: An updated systematic review and meta-analysis Trimetazidine Decreases Risk of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease: A Meta-Analysis of Randomized Controlled Trials.Trimetazidine does not alter metabolic substrate oxidation in cardiac mitochondria of target patient population.Preventive effect of pretreatment with intravenous nicorandil on contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography (PRINCIPLE Study).The effect of L-carnitine on oxidative stress responses of experimental contrast-induced nephropathy in rats.Trimetazidine and cardioprotection: facts and perspectives.Contrast-induced acute kidney injury: A review of practical points.Preventing contrast nephropathy in catheter laboratory.Protective Role of Trimetazidine Against Neomycin-induced Hair Cell Damage in Zebrafish Effects of trimetazidine on the Akt/eNOS signaling pathway and oxidative stress in an in vivo rat model of renal ischemia-reperfusion.Effect of trimetazidine on preventing contrast-induced nephropathy in diabetic patients with renal insufficiency.Coenzyme Q10 combined with trimetazidine in the prevention of contrast-induced nephropathy in patients with coronary heart disease complicated with renal dysfunction undergoing elective cardiac catheterization: a randomized control study and in vivo Prevention of contrast-induced nephropathy through a knowledge of its pathogenesis and risk factors Effectiveness of contrast-associated acute kidney injury prevention methods; a systematic review and network meta-analysis

P2860

Q26741061-0D063526-AFA1-407C-9D07-A282E854AA6C Q30235510-72453B4E-F0C9-4EDA-8CB7-BCD711B8898E Q35567713-422A246A-892B-479B-AB70-050655EF742E Q36797382-62DDBBF8-2D19-4236-B70A-270D5EDF112F Q36872875-C33C94B7-E20E-4069-A33E-DCE66DA93512 Q37692670-6C3D8A5D-FC07-4552-B517-AA62C6C03064 Q38203492-C7CFDB6E-0A59-4269-94B2-1EF1C2D1DB2B Q39327802-D841FB6C-E4E1-408D-86F6-BF9077060192 Q42409825-19001073-135E-4CC7-A706-F3490C0035EC Q42793589-863F790D-AEE9-47A3-9183-CB9E1E330624 Q46675779-2D0A2D69-72AA-4B69-8487-231096750E72 Q49650869-DD5AC4A1-0D77-48A3-AAB4-B87ABA5528F9 Q55370734-D6892D96-9EE5-478D-BC02-3DB1F180B626 Q59100924-2A9D7E59-B402-4F52-9405-39EFF4DE5296 Q59127199-70AC1128-5C29-4A8C-A21A-C6EBEB4AC032

P2860

Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures

http://www.wikidata.org/entity/Q35954734

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures

@ast

Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures

@en

type

label

Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures

@ast

Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures

@en

prefLabel

Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures

@ast

Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures

@en

P1433

Q35954734-1E871AB7-2622-4C39-BC20-FF11AC24F2B6

P1476

Q35954734-ECF1AC93-09E9-4DB5-843A-1D5E9A0A1E4F

P2093

Q35954734-121F12C3-66CF-4DAB-818E-589BA5BAF214

Q35954734-3C5F9F52-1F9A-4F4C-BB2F-8868F94B1A98

Q35954734-3DBF86EA-1616-4D1D-91A1-4D82879EF424

Q35954734-46D74D39-8880-4745-9A40-9824B7154026

Q35954734-81F8787A-D2BB-499E-8F0E-17FBB5C1AFD7

Q35954734-D6FE1DD9-383B-4766-BF16-02ED02527257

Q35954734-E76862F2-8EEE-424C-AEF4-10A789DB6DFD

P2860

Q35954734-14291D2D-2290-4383-9559-F36907A5153F

Q35954734-16C8CDCE-2EF5-40EF-8EE8-27B7849EF993

Q35954734-1A79BE2E-CF99-4822-98AD-B6C20A7D9261

Q35954734-1D402475-9D4B-495F-8C39-D0B4221BB839

Q35954734-1DF9CC84-1824-4D1E-88AD-3BDDF25D274F

Q35954734-2898E54F-C865-4FEF-AE80-9D4238CE5036

Q35954734-319ECC30-03C0-48F0-BF47-8DAED81A8300

Q35954734-33334341-A479-4F4C-9716-B6766AC083E0

Q35954734-3CC7D58C-B791-4996-9645-CC96FDE56201

Q35954734-4108FA90-9DB6-4AB1-AC8A-AC9900BE860C

P304

Q35954734-C2CED0F6-E274-4182-913E-50F9C7236E23

P31

Q35954734-79EE3FB1-17F1-4C71-AD43-ED3533BC1ED6

P356

Q35954734-A8B2E991-B460-4F87-9BAD-901F981D1101

P407

Q35954734-C37428A4-58E2-4FD2-9318-8CF51BCD8397

P433

Q35954734-F471E79E-F376-4742-AC20-5CF1CDB26E5C

P478

Q35954734-2C59C921-2009-4A19-88BA-53AF354FEB0D

P577

Q35954734-3A225292-6999-458F-9B8D-4D42F7367C4B

P5875

Q35954734-019F3C83-7537-411F-A546-27131B1BD0EC

P698

Q35954734-8FA124FE-857B-4BF9-A3B8-0F265B8B633E

P932

Q35954734-BCD9ED7D-FBDD-4DA3-8B32-64AADBAC9439

P356

HRT.2006.097477

P1433

P1476

Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures

@en

P2093

Alper O Onbasili

http://www.w3.org/2001/XMLSchema#string

Aslihan Karul

http://www.w3.org/2001/XMLSchema#string

Guzel Discigil

http://www.w3.org/2001/XMLSchema#string

Harun Akar

http://www.w3.org/2001/XMLSchema#string

Pinar Agaoglu

http://www.w3.org/2001/XMLSchema#string

Tarkan Tekten

http://www.w3.org/2001/XMLSchema#string

Yavuz Yeniceriglu

http://www.w3.org/2001/XMLSchema#string

P2860

The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase

Trimetazidine counteracts tacrolimus nephrotoxicity in a hypertensive liver transplant patient

Prediction of creatinine clearance from serum creatinine

Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.

Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial.

Past and present attempts to prevent radiocontrast nephropathy.

Contrast nephropathy after coronary angiography.

Regional alterations in renal haemodynamics and oxygenation: a role in contrast medium-induced nephropathy.

Contrast-induced nephrotoxicity in patients undergoing cardiac catheterization.

Radiocontrast-induced renal tubular cell apoptosis: hypertonic versus oxidative stress.

P304

698-702

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/HRT.2006.097477

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P577

2006-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6731316

http://www.w3.org/2001/XMLSchema#string

P698

17065180

http://www.w3.org/2001/XMLSchema#string

P932

1955192

http://www.w3.org/2001/XMLSchema#string